Nadim Ahmed Cullinan Oncology, Inc. (CGEM) insider trading activity

Nadim Ahmed is President and CEO of Cullinan Oncology, Inc.. Currently has a direct ownership of 420,699 shares of CGEM, which is worth approximately $3.6 Million. The most recent transaction as insider was on Dec 23, 2025, when has been sold 9,922 shares (Common Stock) at a price of $10.01 per share, resulting in proceeds of $99,319. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 421K

2.3% 3M change

59.87% 12M change

Total Value Held $3.6 Million

NADIM AHMED Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 23 2025	SELL Open market or private sale	$99,319 $10.01 p/Share	9,922 Reduced 2.3%	420,699 Common Stock
Feb 25 2025	SELL Open market or private sale	$106,872 $8.53 p/Share	12,529 Reduced 2.83%	430,621 Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	180,000 Added 28.89%	443,150 Common Stock
Dec 24 2024	SELL Open market or private sale	$99,708 $11.87 p/Share	8,400 Reduced 3.09%	263,150 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	160,000 Added 37.08%	271,550 Common Stock
Dec 26 2023	SELL Open market or private sale	$39,473 $9.24 p/Share	4,272 Reduced 3.69%	111,550 Common Stock
Jun 28 2023	SELL Open market or private sale	$8,652 $11.4 p/Share	759 Reduced 0.65%	115,822 Common Stock

May 23 2023	SELL Open market or private sale	$6,469 $9.15 p/Share	707 Reduced 0.6%	116,581 Common Stock
Apr 25 2023	SELL Open market or private sale	$7,582 $10.59 p/Share	716 Reduced 0.61%	117,288 Common Stock
Mar 23 2023	SELL Open market or private sale	$7,420 $10.51 p/Share	706 Reduced 0.59%	118,004 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	109,000 Added 47.87%	118,710 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$17,658 $10.9 p/Share	1,620 Added 14.3%	9,710 Common Stock
Jun 06 2022	BUY Open market or private purchase	$100,316 $12.4 p/Share	8,090 Added 50.0%	8,090 Common Stock

Also insider at

BMY

BRISTOL MYERS SQUIBB CO Healthcare

EVP and President, Hematology

GMTX

Gemini Therapeutics, Inc. Healthcare

Nadim Ahmed

President and CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Value

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM

Account